Sponsored Content

NXT USA’s proprietary Digexin formula relieves upset gut in GLP-1 patients

10 Apr 2026

Research indicates that NXT USA’s proprietary formulation, Digexin, addresses various types of gastrointestinal (GI) issues in adults prescribed GLP-1 receptor agonist therapy.

Key ingredients

Digexin features a proprietary blend of okra fruit (Abelmoschus esculentus) and ashwagandha root (Withania somnifera).

These botanicals synergistically support gut health through complementary mechanisms. Okra’s soothing polysaccharides coat and hydrate the intestinal lining, promoting smoother digestion. Meanwhile, ashwagandha root helps the body recalibrate stress responses by lowering cortisol levels and supporting serotonin production.

Clinical benefits

NXT USA says this dual action targets the “interplay between stress and digestion” — helping normalise bowel rhythms, reduce discomfort, and restore balance in seven days.

Eric Anderson, managing director of NXT USA, says these results support Digexin’s potential to complement GLP-1 drugs as it helps to reduce side effects and supports overall well-being.

NXT USA’s proprietary Digexin formula relieves upset gut in GLP-1 patients
Digexin was studied on actual GLP-1 users and is not just another gut-health ingredient that underwent a re-brand.

Clinical study findings

The open-label study included patients experiencing various GI side effects who were taking oral semaglutide, the generic name for GLP-1 drugs like Ozempic or Rybelsus.

For three weeks, the subjects supplemented with Digexin and researchers monitored them for changes in GI comfort and overall well-being.

Participants reported “meaningful improvements” in digestive comfort and function, including reduced constipation, reflux, and swallowing difficulties. They also had more regular and complete bowel movements.

Beyond digestive outcomes, subjects taking Digexin also experienced improvements in sleep quality, reduced perceived stress, and “greater overall quality of life.” The supplement was well tolerated, and no adverse events were reported.

Market impact

“We are not about activating GLP-1 activity,” says Anderson. “Digexin addresses GLP-2 — as in No. 2. That is, constipation that results from dieting strategies. Our research is built on rigorous, reproducible human clinical trials designed for real-world application. Digexin delivers results that consumers can trust and brands can build on.”

Read More

Related news

A new standard for omega-3 experience

A new standard for omega-3 experience

13 Apr 2026

Omega-3 quality is no longer just about purity or concentration. Senses™ by Naturmega delivers ultra-pure, sensory-optimised omega-3 with no taste, no odour, and improved stability.

Read more 
PharmaLinea’s iron supplement delivers improvements in  hemoglobin comparable to ferrous sulfate with fewer side  effects

PharmaLinea’s iron supplement delivers improvements in hemoglobin comparable to ferrous sulfate with fewer side effects

23 Feb 2026

PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.

Read more 
LomaChelateX® – power in magnesium bisglycinate

LomaChelateX® – power in magnesium bisglycinate

12 Feb 2026

Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.

Read more 
Fucoidan leader reports record production

Fucoidan leader reports record production

22 Jan 2026

The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.

Read more 
India Honours Ashwagandha with Commemorative  Postal Stamp at WHO Global Summit

India Honours Ashwagandha with Commemorative Postal Stamp at WHO Global Summit

6 Jan 2026

HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...

Read more 
PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

22 Dec 2025

PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...

Read more 
FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

11 Dec 2025

Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...

Read more 
dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

11 Dec 2025

Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025  dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...

Read more 
Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

11 Dec 2025

Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...

Read more 
Fucoidan specialist takes out top international health award

Fucoidan specialist takes out top international health award

4 Dec 2025

Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.

Read more